Clinical Trial

Efficacy and Safety of TRD205 Tablets for Postoperative Analgesia in Unilateral Total Hip Arthroplasty (Phase IIb)

Study acronym: TRD205
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated April 22, 2026 (before its estimated June 27, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a phase IIa, multicenter ,randomized, double-blind, Double-Dummy, Active- and placebo-controlled study designed to evaluate the efficacy, safety and kinetic characteristics of TRD205 tablets for postoperative analgesia after unilateral hip arthroplasty
Trial Details
NCT Number NCT07543796
Lead Sponsor Beijing Tide Pharmaceutical Co., Ltd
Conditions Postoperative Analgesia After Unilateral Hip Arthroplasty
Enrollment 200 participants
Start Date 2026-03-18
Primary Completion 2026-06-27 (estimated)
Study Completion 2026-07-27 (estimated)
Updated on ClinicalTrials.gov 2026-04-22